Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Caution! 7 Penny Stocks That Have Much Further to Fall

By Thomas Niel, InvestorPlace Contributor
Bottom-fishers should take heed about these seven penny stocks to sell. While each one may at first look like a "buy the dip" opportunity, a closer look suggests further downside ahead.

3 Red-Hot Growth Stocks Set to Surge 100%+ in One Year

By Omor Ibne Ehsan
These growth stocks look poised to stage a turnaround and deliver triple-digit returns in one year. Snap them up while they're cheap!

The 7 Most Undervalued Stocks in the Market Right Now: September 2023

By Omor Ibne Ehsan
Buying these undervalued stocks right now can pay off tremendously once these fundamentally solid businesses ultimately recover.

Why Are Cannabis Stocks Up Today?

By Chris MacDonald, InvestorPlace Contributor
Today, a range of cannabis stocks are surging on news that the Senate is expected to vote on SAFE banking reforms.

The 7 Most Undervalued Cathie Wood Stocks to Buy in September 2023

By Muslim Farooque, InvestorPlace Contributor
Elevate your portfolio with these Cathie Wood's undervalued stocks brimming with robust long-term growth potential

Why Is Canopy Growth (CGC) Stock Up 14% Today?

By William White, InvestorPlace Writer
Canopy Growth (CGC) stock is rising higher on Friday after the cannabis company announced it would cease funding BioSteel Sports Nutrition.

NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff

By William White, InvestorPlace Writer
Novartis (NVS) stock is rising higher on Friday after the company announced approval for the spinoff of its generic drugs business Sandoz.

Betting With the ‘Big Short’: 3 Michael Burry Stocks to Bank On

By Yiannis Zourmpanos, InvestorPlace Contributor
Burry's insight and strategic thinking led him to invest in three seemingly disparate industries.

Why Is Axcella Health (AXLA) Stock Down 24% Today?

By William White, InvestorPlace Writer
Axcella Health (AXLA) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split.

Why Is Moleculin Biotech (MBRX) Stock Is Moving Today?

By William White, InvestorPlace Writer
Moleculin Biotech (MBRX) stock is on the move Friday after the clinical-stage pharmaceutical company provided an update to investors.

The 7 Most Undervalued Small-Cap Stocks to Buy in September 2023

By Faisal Humayun, InvestorPlace Contributor
These are the small-cap stocks to buy and hold for multibagger returns

The 3 Most Undervalued Under-$1 Stocks to Buy in September 2023

By Tyrik Torres, InvestorPlace Contributor
Cheap valuations and prospects for future growth should get individual investors excited for these under-$1 stocks to buy.

The 7 Best Meme Stocks to Buy Now: September 2023

By Thomas Niel, InvestorPlace Contributor
Let's take a look at seven past and present favorites of the Reddit set, each of which should be considered one of the best meme stocks to buy right now.

Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains

By Muslim Farooque, InvestorPlace Contributor
Unearth the best healthcare stocks to buy that are poised for long-term growth ahead for savvy investors at this time

Should You Buy NVO Stock Ahead of the Novo Nordisk Stock Split?

By Samuel O'Brient, InvestorPlace Reporter
Ozempic producer Novo Nordisk is about to split its stock again. Here's why investors should be watching NVO stock closely.

Why Is Rocket Pharmaceuticals (RCKT) Stock Up 35% Today?

By Josh Enomoto, InvestorPlace Contributor
With Rocket Pharmaceuticals reaching a Phase II agreement with the FDA, RCKT stock soared, though some concerns linger.

The 3 Most Undervalued REITs to Buy in September 2023

By Noah Bolton, InvestorPlace Contributor
The companies below offer fair valuations, possible future growth, and little fluctuations in their underlaying share prices.

Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm

By Josh Enomoto, InvestorPlace Contributor
Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony.

The 3 Most Undervalued Cannabis Stocks to Buy in September 2023

By Joel Baglole, InvestorPlace Contributor
The dire situation has led to extremely cheap valuations on many cannabis stocks, potentially offering an opportunity to investors.
Load More Articles